EXPERIMENTAL STUDIES OF THE PATHOGENESIS OF FELINE LEUKEMIA VIRUS INFECTION NLM AIDSLINE Important note: Information in this article was accurate in 1986. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


EXPERIMENTAL STUDIES OF THE PATHOGENESIS OF FELINE LEUKEMIA VIRUS INFECTION

Dev Oncol; 28:267-88 1985. Unique Identifier : AIDSLINE ICDB/86621742
Hoover EA; Dept. of Pathology, College of Veterinary Medicine and Biological; Science, Colorado State Univ., Fort Collins, CO 80523


Abstract: Characteristics of feline leukemia virus (FeLV) infection and the disease progression are reviewed under the following headings: transmission of FeLV, FeLV strain- and age-related resistance, early FeLV-target cell interactions and resultant virus-host relationships, preleukemic changes, aplastic anemia, feline acquired immune deficiency syndrome (FAIDS), embryonic mortality and covert congenital infection, and FeLV latency and reactivation. Experiments with SPF cats inoculated with standard doses (10(5) focus-forming units) of FeLV-Rickard established that, within 6 wk after viral exposure, either of two major host-virus relationships evolve: (1) progressive infection characterized by productive infection of systemic hemolymphatic cells, persistent viremia, and minimal anti-feline onco RNA virus-associated cell membrane antigen and antiviral immune response, or (2) regressive infection characterized by early curtailment of viral replication in hemolymphatic cells, transient or absent viremia, and substantial antiviral immune response. Preleukemic events in infected cats include atrophy of the thymus, impairment of cell-mediated immunity and T helper cell-dependent humoral antibody responses, redistribution of certain lymphoid cells subsets, and eventual clonal proliferation of T lymphoblasts arising with the atrophied thymus. Pathogenesis of FeLV aplastic anemia appears to involve cytopathic viral deletion of early erythroid progenitor cells, which are recognized as burst-forming units-erythroid in clonogenic bone marrow colony-forming cell culture assays. Impairment of cell-mediated immune functions, dramatic depletion of T or both T and B cell regions in lymphoid tissues, debilitative wt loss, and severe opportunistic infections characterize FAIDS. Embryonic mortality and placental involution ensued in 78% of viremic cats in one experiment. Data obtained with the feline retrovirus system provide a link between the highly-expressed retroviruses of inbred chickens and mice and the highly-repressed retroviruses of wild mice, cattle, sheep, horses, macaques, gibbon apes, and man. (69 Refs)
Keywords: Age Factors Anemia, Aplastic/MICROBIOLOGY Animal Antibodies, Viral/ANALYSIS Antigens, Viral/IMMUNOLOGY Cats Cytopathogenic Effect, Viral Immunologic Deficiency Syndromes/MICROBIOLOGY Leukemia Virus, Feline/IMMUNOLOGY/PATHOGENICITY Leukemia, Experimental/IMMUNOLOGY/*MICROBIOLOGY Lymphoma/MICROBIOLOGY Thymus Neoplasms/MICROBIOLOGY Virulence Virus Activation MEETING PAPER


861130
M86B0246


Copyright © 1986 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1986. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1986. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .